Gynecology

>

Latest News

FDA grants IND clearance to DARE-VVA1 for dyspareunia | Image Credit: © Postmodern Studio - © Postmodern Studio - stock.adobe.com.
FDA grants IND clearance to DARE-VVA1 for dyspareunia

December 7th 2023

Daré Bioscience's tamoxifen-based therapy, DARE-VVA1, secures FDA clearance for an investigational new drug application, offering hope for women with contraindications to estrogen therapies suffering from the underdiagnosed condition of vulvar and vaginal atrophy.

Exploring menstrual health: Insights from the Avon longitudinal study | Image Credit: © Alena - © Alena - stock.adobe.com.
Exploring menstrual health: Insights from the Avon longitudinal study

December 5th 2023

Metronidazole treatment failure and persistent bacterial vaginosis: Implications for HIV susceptibility | Image Credit: © fizkes - © fizkes - stock.adobe.com.
Metronidazole treatment failure and persistent bacterial vaginosis: Implications for HIV susceptibility

November 30th 2023

Early intrauterine balloon tamponade and severe postpartum hemorrhage risk   Image Credit: © Monkey Business - © Monkey Business - stock.adobe.com.
Early intrauterine balloon tamponade and severe postpartum hemorrhage risk

November 14th 2023

Treating heavy menstrual bleeding: Levonorgestrel system vs combined oral contraceptives | Image Credit: © Jo Panuwat D - © Jo Panuwat D - stock.adobe.com.
Treating heavy menstrual bleeding: Levonorgestrel system vs combined oral contraceptives

November 8th 2023

More News

© 2023 MJH Life Sciences

All rights reserved.